PROBIOTICS AND UNDERNOURISHMENT IMPACT ON BRAIN 5-HT SYSTEM AND NEUROTROPHIN BDNF IN RATS: RISK OF DEPRESSION AND ANXIETY? DOI
Simone Evangelista Fonseca,

Cláudia Cristina Alves,

Clarissa Tavares Dias

et al.

Nutrition, Journal Year: 2024, Volume and Issue: 132, P. 112680 - 112680

Published: Dec. 31, 2024

Language: Английский

Probiotics and Food Bioactives: Unraveling Their Impact on Gut Microbiome, Inflammation, and Metabolic Health DOI
Alice Njolke Mafe, Great Iruoghene Edo, Patrick Othuke Akpoghelie

et al.

Probiotics and Antimicrobial Proteins, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 14, 2025

Language: Английский

Citations

10
Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects DOI
Bushra Bashir, Monica Gulati, Sukriti Vishwas

et al.

Ageing Research Reviews, Journal Year: 2025, Volume and Issue: unknown, P. 102689 - 102689

Published: Feb. 1, 2025

Language: Английский

Citations

3
Psychobiotics Ameliorate Depression and Anxiety Status in Surgical Oncology Patients: Results from the ProDeCa Study DOI Open Access
Georgios Tzikos,

E. Chamalidou,

Dimitra Christopoulou

et al.

Nutrients, Journal Year: 2025, Volume and Issue: 17(5), P. 857 - 857

Published: Feb. 28, 2025

Background: Psychological disorders are prevalent in patients having undergone gastrointestinal cancer surgery, and their emotional status may further deteriorate during subsequent chemotherapy. Psychobiotics specific probiotics that have the unique characteristics of producing neuroactive substances thought to act on brain-gut axis. The aim present study was evaluate benefits a psychobiotic formula depression anxiety status, as well perceived stress, versus placebo chemotherapy course following surgery for cancer. Patients: enrolled patients, allocated groups, were assessed by means these psychometric tests: Beck's Depression Inventory Hamilton Rating 17-item Scale depression; General Anxiety Disorder-7 anxiety; Perceived Stress Scale-14 Item stress at three time-points: upon allocation [T1], after one month treatment [T2], two months thereafter [T3]. Results: In total, 266 included. One improved [i] 60.4% [48 depressed T1, reduced 16 T3]; [ii] 57.0% [72 26 [iii] [42 14 T3]. placebo-treated experienced deterioration all parameters studied, i.e., increased 62.9%, 39.7%, 142.5%. Conclusions: Based findings, it can be recognized has great potential every patient risk suffering from depression, anxiety, or surgery/chemotherapy

Language: Английский

Citations

1
Exploring Therapeutic Potential of Phytoconstituents as a Gut Microbiota Modulator in the Management of Neurological and Psychological Disorders DOI

Prarit Chandel,

Komal Thapa, Neha Kanojia

et al.

Neuroscience, Journal Year: 2024, Volume and Issue: 551, P. 69 - 78

Published: May 14, 2024

Language: Английский

Citations

4
Postbiotics-peptidoglycan, lipoteichoic acid, exopolysaccharides, surface layer protein and pili proteins—Structure, activity in wounds and their delivery systems DOI
Wang Pu,

Shuxin Wang,

Donghui Wang

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 274, P. 133195 - 133195

Published: June 15, 2024

Language: Английский

Citations

4
Living-loaded hydrogel: Strategies for loading living, interactions between loaded living and hydrogel, and applications DOI
Ran Zhang, Xueyao Liu,

Yanzhe Gou

et al.

European Polymer Journal, Journal Year: 2024, Volume and Issue: 213, P. 113130 - 113130

Published: May 15, 2024

Language: Английский

Citations

3
Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders DOI
Azhagu Madhavan Sivalingam

Clinical Reviews in Allergy & Immunology, Journal Year: 2025, Volume and Issue: 68(1)

Published: Feb. 11, 2025

Language: Английский

Citations

0
Gut Microbes: Therapeutic Target for Neuropsychiatric Disorders DOI
Keya Mallick, Gopal Khodve,

Ritika Ruwatia

et al.

Journal of Psychiatric Research, Journal Year: 2025, Volume and Issue: 184, P. 27 - 38

Published: Feb. 21, 2025

Language: Английский

Citations

0
In Vitro and In Silico Assessment of the Probiotic and Technological Potential of Lacticaseibacillus rhamnosus MW019593 Isolated from Algerian Cow’s Milk DOI
Nassim Madi, Amine M. Boukerb,

Loubna Mekdade

et al.

Probiotics and Antimicrobial Proteins, Journal Year: 2025, Volume and Issue: unknown

Published: March 13, 2025

Language: Английский

Citations

0
Nutraceuticals for Gut–Brain Axis Health: A Novel Approach to Combat Malnutrition and Future Personalised Nutraceutical Interventions DOI Open Access

Litai Liu,

Wen Qi,

Na Zhang

et al.

Nutrients, Journal Year: 2025, Volume and Issue: 17(9), P. 1551 - 1551

Published: April 30, 2025

The gut-brain axis (GBA) is a bidirectional communication network between the gastrointestinal tract and brain, modulated by gut microbiota related biomarkers. Malnutrition disrupts GBA homeostasis, exacerbating dysfunction through dysbiosis, impaired neuroactive metabolite production, systemic inflammation. Nutraceuticals, including probiotics, prebiotics, synbiotics, postbiotics, paraprobiotics, offer promising approach to improving homeostasis modulating composition metabolites. This review aims elucidate interplay microbiota-derived biomarkers in malnutrition evaluate potential of nutraceuticals combating malnutrition. Furthermore, it explores future personalised nutraceutical interventions tailored individual genetic microbiome profiles, providing targeted optimise health outcomes. integration into management could transform treatment improve cognitive metabolic health.

Language: Английский

Citations

0